Bexorg Wins MJFF Grant for TRPML1-Targeted Parkinson`s Therapies
28 Jan 2026 //
GLOBENEWSWIRE
Bexorg Appoints Sean Murphy, Ph.D., As Chief Technology Officer
12 Nov 2025 //
GLOBENEWSWIRE
Bexorg Secures $42.5M To Revolutionize CNS Drug Development
15 Oct 2025 //
GLOBENEWSWIRE
Bexorg Collaborates with Biohaven to Enhance CNS Drug Development
10 Jun 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support